0 Beoordelingen

ID

36208

Beschrijving

Study ID: 101963 Clinical Study ID: SCA101963 Study Title: A randomised, blinded, parallel group study to investigate the potential pharmacokinetic interaction between lamotrigine and risperidone in healthy, non-smoking, male volunteers. Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: lamotrigine Trade Name: Lamictal XR,Lamictal,LAMICTIN Study Indication: Schizophrenia

Trefwoorden

  1. 22-04-19 22-04-19 -
Houder van rechten

GlaxoSmithKline

Geüploaded op

22 april 2019

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY-NC 3.0

Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Itemgroep Commentaren voor :

Item Commentaren voor :


    Geen commentaren

    U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

    Potential Pharmacokinetic Interaction between Lamotrigine and Risperidone; 101963

    Investigational Product Discontinuation

    Administrative Data
    Beschrijving

    Administrative Data

    Alias
    UMLS CUI-1
    C1320722
    Subject Identifier
    Beschrijving

    Clinical Trial Subject Unique Identifier

    Datatype

    integer

    Alias
    UMLS CUI [1]
    C2348585
    Investigational Product Discontinuation
    Beschrijving

    Investigational Product Discontinuation

    Alias
    UMLS CUI-1
    C0304229
    UMLS CUI-2
    C0457454
    Was the investigational product stopped permanently before the end of the scheduled treatment period?
    Beschrijving

    Experimental drug, Discontinuation, Permanent

    Datatype

    boolean

    Alias
    UMLS CUI [1,1]
    C0304229
    UMLS CUI [1,2]
    C0457454
    UMLS CUI [1,3]
    C0205355
    If Yes, tick the primary reason the investigational product was stopped
    Beschrijving

    Experimental drug, Discontinuation, Permanent, Indication

    Datatype

    text

    Alias
    UMLS CUI [1,1]
    C0304229
    UMLS CUI [1,2]
    C0457454
    UMLS CUI [1,3]
    C0205355
    UMLS CUI [1,4]
    C4288399
    UMLS CUI [1,5]
    C0392360

    Similar models

    Investigational Product Discontinuation

    Name
    Type
    Description | Question | Decode (Coded Value)
    Datatype
    Alias
    Item Group
    Administrative Data
    C1320722 (UMLS CUI-1)
    Clinical Trial Subject Unique Identifier
    Item
    Subject Identifier
    integer
    C2348585 (UMLS CUI [1])
    Item Group
    Investigational Product Discontinuation
    C0304229 (UMLS CUI-1)
    C0457454 (UMLS CUI-2)
    Experimental drug, Discontinuation, Permanent
    Item
    Was the investigational product stopped permanently before the end of the scheduled treatment period?
    boolean
    C0304229 (UMLS CUI [1,1])
    C0457454 (UMLS CUI [1,2])
    C0205355 (UMLS CUI [1,3])
    Item
    If Yes, tick the primary reason the investigational product was stopped
    text
    C0304229 (UMLS CUI [1,1])
    C0457454 (UMLS CUI [1,2])
    C0205355 (UMLS CUI [1,3])
    C4288399 (UMLS CUI [1,4])
    C0392360 (UMLS CUI [1,5])
    Code List
    If Yes, tick the primary reason the investigational product was stopped
    CL Item
    Adverse event (1)
    CL Item
    Lost to follow-up (2)
    CL Item
    Protocol violation (3)
    CL Item
    Subject decided to withdraw from the study [6] D Sponsor terminated study (4)
    CL Item
    Other (5)

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial